Paratek Pharmaceuticals Garners $18,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01956eee-ef43-4c5d-bcef-45781f022750&Preview=1 -
Date
4/16/2008 -
Company Name
Paratek Pharmaceuticals -
Mailing Address
75 Kneeland Street Boston, MA 02111 -
Company Description
Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases. -
Website
http://www.paratekpharm.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. This is part of a $40 million funding. -
M&A Terms
-
Venture Investor
Aisling Capital -
Venture Investor
D. E. Shaw Group -
Venture Investor
Nomura Phase4 Ventures -
Venture Investor
Novartis BioVenture Fund -
Venture Investor
HBM Bioventures -
Venture Investor
Hercules Technology Growth Capital
